
News|Articles|June 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 3, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, June 3, 2022, at 3:34 PM, EDT:
46.8% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.7% of total US population
• 70.9% of US population aged ≥5 years
• 75.1% of US population aged ≥12 years
• 76.6% of US population aged ≥18 years
• 91.1% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, June 3, 2022 at 3:20 PM, EDT, there have been:
• 84 630 637 confirmed cases and
• 1 008 259 deaths
• 1 008 259 deaths
In the past 28 days, the 3 states with the most new cases are:
1. California: 342 133
2. New York: 247 321
3. Florida: 230 231
2. New York: 247 321
3. Florida: 230 231
Deaths: California has the highest number of deaths due to COVID-19 with 91 490 reported fatalities, followed by Texas with 88 385 and Florida with 74 588.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 531 217 249 confirmed cases, 6 297 235 deaths, and 11 657 114 373 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Investigational Oral Agent ALZ-801 Slows Brain Atrophy and Cognitive Decline in APOE4 Homozygotes with Early AD
2
Why Do Women Suffer in Silence with Genitourinary Syndrome of Menopause?
3
Mazdutide Demonstrates Superior Glycemic Control and Weight Loss vs Semaglutide in Head-to-Head Trial
4
Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk
5








































































































































































































































































































